InjectionCritical Care Injection Infusion

DOXORUBICIN INJECTION L-ASPARAGINASE INJECTION PACLITAXEL INJECTION

Doxorubicin + L-Asparaginase + Paclitaxel · Antineoplastic agents (anthracycline, enzyme and taxane)

InjectionCritical Care Injection Infusion

DOXORUBICIN INJECTION L-ASPARAGINASE INJECTION PACLITAXEL INJECTIONProspero Healthcare

Doxorubicin + L-Asparaginase + Paclitaxel is an antineoplastic agents (anthracycline, enzyme and taxane) supplied as an injection. It is used in standard clinical practice for chemotherapy for solid tumours and chemotherapy for leukaemia and lymphoma, as described in general pharmacological references.

Uses

Chemotherapy for solid tumours
Chemotherapy for leukaemia and lymphoma

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Doxorubicin + L-Asparaginase + Paclitaxel
Dosage form: Injection
Therapeutic category: Critical Care Injection Infusion
Therapeutic class: Antineoplastic agents (anthracycline, enzyme and taxane)
Packing: Vial or ampoule, single unit or tray pack
Storage: Store below 25 °C, protected from light. Do not freeze.

02Related

From the same category

View the category